Publications by authors named "J A Roukema"
Article Synopsis
- Portable spirometers are becoming popular for measuring lung function at home, but there are concerns about their accuracy, which impacts the management of chronic respiratory diseases.
- The study aimed to evaluate the accuracy, repeatability, and responsiveness of home spirometry for cystic fibrosis patients in both children and adults across multiple Dutch centers.
- Results indicated that home spirometry measurements consistently showed lower values than clinic measurements, suggesting potential limitations in using these devices for accurate lung function assessment.
Background: Remote care usefulness and climate change co-benefits should be addressed simultaneously to incentivize political action.
Objectives: To assess the changes in healthcare consumption, lung function and greenhouse gas (GHG) emissions during the COVID-19 pandemic in Dutch cystic fibrosis (CF) care.
Design: Retrospective multicentre observational study in five Dutch CF centres.
Potential, Pitfalls, and Future Directions for Remote Monitoring of Chronic Respiratory Diseases: Multicenter Mixed Methods Study in Routine Cystic Fibrosis Care.
J Med Internet Res
August 2024
Background: The current literature inadequately addresses the extent to which remote monitoring should be integrated into care models for chronic respiratory diseases (CRDs).
Objective: This study examined a remote monitoring program (RMP) in cystic fibrosis (CF) by exploring experiences, future perspectives, and use behavior over 3 years, with the aim of developing future directions for remote monitoring in CRDs.
Methods: This was a mixed methods, multicenter, observational study in 5 Dutch CF centers following a sequential explanatory design.
Purpose: Adolescent idiopathic scoliosis (AIS) presents various challenges, including respiratory symptoms that impact pulmonary function. This study aims to explore the feasibility of using a smart shirt for continuous monitoring of lung volumes and heart rate during routine activities in AIS patients.
Methods: A single-center exploratory feasibility study was conducted with AIS patients aged 16-22 years with a thoracic curvature of ≥ 30 degrees and absence of respiratory comorbidities.
Limited data on the clinical management of drug-drug interactions between triazoles and Cystic Fibrosis transmembrane conductance regulator (CFTR) modulators are available. We retrospectively evaluated azole target attainment and dose adaptations in patients from two Dutch CF centres concomitantly receiving triazoles and CFTR modulators. In total, 21 patients with 59 triazole trough concentrations were evaluated.
View Article and Find Full Text PDF